cell
TH17 Cell
Barrier helper state that recruits neutrophils and protects against extracellular bacteria and fungi
Review layer
Last reviewed 2026-05-17
Systems teaching draft. Content is structured for education and graph expansion, with formal source tagging ready for the next review pass.
State signature
Systems profile
System effects
Primary mapped axes from existing Atlas data.
Tissue
Organ, barrier, stromal, vascular, or local niche behavior.
Inflammation
Inflammatory alarm, recruitment, mediator release, or tissue-damaging amplification.
Metabolism
Energy allocation, glycolysis, mitochondrial strain, lipid signaling, or nutrient-sensitive behavior.
Local map
Relationship field
Arrows point from the upstream source toward the receiving target. Restraint edges use a bar; association edges stay dashed because they are not causal arrows.
Selected relationship
IL-6, TGF-beta, and IL-1beta support TH17 differentiation
Read as source supporting or biasing the target state.
What this relationship means
Read this as Naive CD4 T Cell influencing TH17 Cell; the arrow names the direction, while the details explain the likely system domain.
Effect of source
Naive CD4 T Cell is the upstream signal or context.
Effect on target
TH17 Cell is the receiving node whose behavior may shift.
Use with caution
Use this as a map-reading aid, not as diagnosis, triage, treatment guidance, or a risk score.
System effect
Naive CD4 T Cell influences TH17 Cell; the axes below show which mapped systems carry that relationship.
Inflammation
Inflammatory alarm, recruitment, mediator release, or tissue-damaging amplification.
Tissue
Organ, barrier, stromal, vascular, or local niche behavior.
Chronicity
Memory, priming, fibrosis, exhaustion, remodeling, or other time-dependent drift.
Axes are mapped cues from Atlas data, not clinical predictions.
Evidence context
Curated edge, reviewed endpoints, and mapped external anchors.
TCR signaling
R-HSA-202403 - checked 2026-06-28
Graph neighborhood
Direct relationships
Arrow shows upstream source toward receiving target.
IL-6, TGF-beta, and IL-1beta support TH17 differentiation
Context link: no causal arrow.
TH17 cells coordinate IL-17-rich mucocutaneous barrier defense and neutrophil recruitment
Network behavior
Systems Overview
TH17 cells produce IL-17-family signals that drive epithelial chemokines, neutrophil recruitment, antimicrobial peptides, and barrier inflammation.
Lineage
Origin
Naive CD4 T cell -> IL-6/TGF-beta/IL-1beta priming -> RORγt-positive TH17 cell
Transcription factors: RORγt, STAT3, BATF, IRF4
Lifecycle Visualizer
days
Barrier priming
RORγt induction
days-weeks
Stabilization
Pathogenic or protective TH17
days-weeks
Effector loop
Epithelial chemokine induction
weeks-months
Resolution or persistence
Treg/SCFA control or chronic barrier inflammation
Activation and Suppression
Surface and Secreted Signals
Metabolic State
Programs
Acute: Epithelial IL-17 response increases CXCL8-like chemokines and neutrophil recruitment.
Chronic: Persistent TH17 tone can sustain psoriasis-like, gut, joint, and autoimmune inflammation.
Tissue Roles
gut: Microbiome-linked barrier defense and inflammatory bowel risk.
lung: Neutrophilic airway inflammation and fungal defense.
skin: Psoriasis-like keratinocyte activation and antimicrobial peptide programs.
lymphoid: Can be reinforced by IL-23-rich dendritic cell programs.
Disease Associations
Clinical Pearls
- TH17 connects microbiome ecology to neutrophil-heavy barrier inflammation.
- IL-23 often stabilizes chronic pathogenic TH17 behavior.
- TH17 is not simply bad; it is essential for fungal and extracellular bacterial defense.